|
Volumn 260, Issue 1, 2013, Pages 343-345
|
Alemtuzumab for multiple sclerosis: A new age of immunotherapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
BETA1A INTERFERON;
DRUG EFFICACY;
HUMAN;
IMMUNOTHERAPY;
MULTIPLE SCLEROSIS;
NOTE;
PRIORITY JOURNAL;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RELAPSE;
|
EID: 84870728542
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-012-6786-x Document Type: Note |
Times cited : (2)
|
References (0)
|